Swiss Life Asset Management »

Xeris Pharmaceuticals shares owned by Swiss Life Asset Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Swiss Life Asset Management from 13F filings

Historical chart of Swiss Life Asset Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Swiss Life Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Swiss Life Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $205k 26k 7.85

More positions owned by Swiss Life Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Verizon Communications (VZ)
Johnson & Johnson (JNJ)
Altria (MO)
Visa Com Cl A (V)
Pfizer (PFE)

View all positions for Swiss Life Asset Management

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Parkman Healthcare Partners
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Legal & General Group
CenterBook Partners

View all funds holding Xeris Pharmaceuticals